|
|
|
|
|
Analogs
-
3881666
-
-
3953891
-
-
3977785
-
-
4398249
-
-
4535881
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 33 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
5HT2A-1-E |
Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1622 |
0.31 |
Binding ≤ 10μM
|
5HT2C-1-E |
Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10000 |
0.27 |
Binding ≤ 10μM
|
AA3R-1-E |
Adenosine Receptor A3 (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
95 |
0.38 |
Binding ≤ 10μM
|
ADA1A-1-E |
Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1057 |
0.32 |
Binding ≤ 10μM
|
ADA1B-1-E |
Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
966 |
0.32 |
Binding ≤ 10μM
|
ADA1D-1-E |
Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
289 |
0.35 |
Binding ≤ 10μM
|
ADA2A-1-E |
Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
ADA2A-1-E |
Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
49 |
0.39 |
Binding ≤ 10μM
|
ADA2B-1-E |
Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7 |
0.44 |
Binding ≤ 10μM
|
ADA2B-1-E |
Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
54 |
0.39 |
Binding ≤ 10μM
|
ADA2C-1-E |
Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
ADA2C-1-E |
Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
54 |
0.39 |
Binding ≤ 10μM
|
CAC1C-1-E |
Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.40 |
Binding ≤ 10μM
|
DRD1-1-E |
Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2000 |
0.31 |
Binding ≤ 10μM
|
DRD3-1-E |
Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2430 |
0.30 |
Binding ≤ 10μM
|
DRD4-3-E |
Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
2000 |
0.31 |
Binding ≤ 10μM
|
DRD5-1-E |
Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.31 |
Binding ≤ 10μM
|
ADA2A-2-E |
Alpha-2a Adrenergic Receptor (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
165 |
0.37 |
Functional ≤ 10μM
|
ADA2B-2-E |
Alpha-2b Adrenergic Receptor (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
165 |
0.37 |
Functional ≤ 10μM
|
ADA2C-2-E |
Alpha-2c Adrenergic Receptor (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
165 |
0.37 |
Functional ≤ 10μM
|
CP2D6-1-E |
Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.44 |
ADME/T ≤ 10μM
|
CP2D6-1-E |
Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
80 |
0.38 |
ADME/T ≤ 10μM
|
DRD2-4-E |
Dopamine D2 Receptor (cluster #4 Of 24), Eukaryotic |
Eukaryotes |
2000 |
0.31 |
Binding ≤ 10μM
|
Z104304-1-O |
Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other |
Other |
360 |
0.35 |
Binding ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
3162 |
0.30 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
1100 |
0.32 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
505 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.22 |
8.17 |
-43.2 |
3 |
5 |
1 |
67 |
355.458 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.22 |
6.05 |
-10.14 |
2 |
5 |
0 |
66 |
354.45 |
2 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GRM1-1-E |
Metabotropic Glutamate Receptor 1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
106 |
0.41 |
Binding ≤ 10μM
|
GRM1-1-E |
Metabotropic Glutamate Receptor 1 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
1 |
0.53 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
77 |
0.41 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.61 |
7.01 |
-12.95 |
0 |
4 |
0 |
48 |
325.408 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
3000 |
0.28 |
Functional ≤ 10μM
|
Z80566-2-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #2 Of 2), Other |
Other |
3000 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
7.91 |
17.91 |
-5.99 |
0 |
2 |
0 |
26 |
400.628 |
17 |
↓
|
|
|
Analogs
-
6474088
-
-
6474144
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
13 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.05 |
10.42 |
-52.15 |
1 |
5 |
-1 |
79 |
401.866 |
7 |
↓
|
|
|
Analogs
-
34690226
-
-
34690227
-
-
34690228
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HSF1-1-E |
Heat Shock Factor Protein 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2600 |
0.24 |
Binding ≤ 10μM
|
PTN11-2-E |
Protein-tyrosine Phosphatase 2C (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
80 |
0.30 |
Functional ≤ 10μM
|
Z80387-2-O |
PC-12 (Adrenal Phaeochromacytoma Cells) (cluster #2 Of 3), Other |
Other |
3150 |
0.23 |
Functional ≤ 10μM |
Z80418-3-O |
RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #3 Of 9), Other |
Other |
270 |
0.28 |
Functional ≤ 10μM
|
Z81170-2-O |
LNCaP (Prostate Carcinoma) (cluster #2 Of 5), Other |
Other |
2500 |
0.24 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.06 |
12.71 |
-61.14 |
1 |
4 |
-1 |
77 |
449.611 |
1 |
↓
|
Lo
Low (pH 4.5-6)
|
5.06 |
10.72 |
-16.51 |
2 |
4 |
0 |
75 |
450.619 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.49 |
-5.48 |
-56.11 |
3 |
7 |
-1 |
102 |
386.472 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.49 |
7.62 |
-52.86 |
3 |
7 |
-1 |
103 |
386.472 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.44 |
-1.98 |
-51.87 |
2 |
5 |
-1 |
89 |
373.469 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.44 |
7.35 |
-54.7 |
2 |
5 |
-1 |
90 |
373.469 |
6 |
↓
|
|
|
Analogs
-
5758597
-
-
5758598
-
-
16952044
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
1400 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.96 |
-8.52 |
-20.02 |
4 |
7 |
0 |
110 |
245.21 |
2 |
↓
|
|
|
|
|
|
|
Analogs
-
5758597
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
1400 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.96 |
-4.85 |
-31.98 |
4 |
7 |
0 |
111 |
245.21 |
2 |
↓
|
|
|
|
|
Analogs
-
3956771
-
-
25057
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
900 |
0.47 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.97 |
-3.76 |
-11.23 |
3 |
7 |
0 |
105 |
256.258 |
3 |
↓
|
|
|
Analogs
-
3956771
-
-
25057
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
900 |
0.47 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.97 |
-3.53 |
-10.2 |
3 |
7 |
0 |
105 |
256.258 |
3 |
↓
|
|
|
Analogs
-
3956771
-
-
25057
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
900 |
0.47 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.97 |
-2.68 |
-18.02 |
3 |
7 |
0 |
105 |
256.258 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.62 |
14.36 |
-8.48 |
1 |
3 |
0 |
42 |
383.576 |
16 |
↓
|
|
|
Analogs
-
33820105
-
-
33820106
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
-2.15 |
-56.17 |
2 |
5 |
-1 |
89 |
397.491 |
8 |
↓
|
|
|
Analogs
-
33820105
-
-
33820106
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.17 |
8.01 |
-56.2 |
2 |
5 |
-1 |
90 |
397.491 |
8 |
↓
|
|
|
Analogs
-
3977873
-
-
3977874
-
-
3977875
-
-
4245621
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CASP3-1-E |
Caspase-3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.20 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
200 |
0.22 |
Functional ≤ 10μM
|
Z100752-1-O |
Renca (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2900 |
0.18 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
3920 |
0.18 |
Functional ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
130 |
0.23 |
Functional ≤ 10μM
|
Z103413-1-O |
SW948 (cluster #1 Of 1), Other |
Other |
1300 |
0.20 |
Functional ≤ 10μM
|
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
5012 |
0.18 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
990 |
0.20 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.21 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2150 |
0.19 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
360 |
0.21 |
Functional ≤ 10μM |
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9000 |
0.17 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
1200 |
0.20 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
100 |
0.23 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
350 |
0.22 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
380 |
0.21 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
5160 |
0.18 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
970 |
0.20 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
750 |
0.20 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
6600 |
0.17 |
Functional ≤ 10μM
|
Z80179-1-O |
J82 (Bladder Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM |
Z80186-9-O |
K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other |
Other |
522 |
0.21 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
567 |
0.21 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
834 |
0.20 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2300 |
0.19 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
878 |
0.20 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
600 |
0.21 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
65 |
0.24 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80288-1-O |
MOVP-3 (cluster #1 Of 1), Other |
Other |
7550 |
0.17 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
1250 |
0.20 |
Functional ≤ 10μM
|
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
1500 |
0.19 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
50 |
0.24 |
Functional ≤ 10μM
|
Z80390-2-O |
PC-3 (Prostate Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
7800 |
0.17 |
Functional ≤ 10μM
|
Z80435-1-O |
RT-112 (cluster #1 Of 1), Other |
Other |
220 |
0.22 |
Functional ≤ 10μM
|
Z80436-1-O |
RT-4 (cluster #1 Of 1), Other |
Other |
1330 |
0.20 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
150 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
300 |
0.22 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
5720 |
0.17 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
850 |
0.20 |
Functional ≤ 10μM
|
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
2500 |
0.19 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
275 |
0.22 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z80546-1-O |
TERT-RPE1 (Retinal Pigmented Epithelial Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z80548-4-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #4 Of 5), Other |
Other |
2160 |
0.19 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
3480 |
0.18 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
140 |
0.23 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
1320 |
0.20 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
9980 |
0.17 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
3667 |
0.18 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
740 |
0.20 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
591 |
0.21 |
Functional ≤ 10μM
|
Z80866-1-O |
GLC4 Cell Line (cluster #1 Of 1), Other |
Other |
820 |
0.20 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1590 |
0.19 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1192 |
0.20 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
550 |
0.21 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
9500 |
0.17 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
3250 |
0.18 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
985 |
0.20 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM
|
Z81126-1-O |
KYSE-150 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81128-1-O |
KYSE-520 Cell Line (cluster #1 Of 1), Other |
Other |
410 |
0.21 |
Functional ≤ 10μM
|
Z81130-1-O |
KYSE-70 Cell Line (cluster #1 Of 1), Other |
Other |
790 |
0.20 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
180 |
0.22 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
577 |
0.21 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
8930 |
0.17 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
80 |
0.24 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
900 |
0.20 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.22 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
3930 |
0.18 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.70 |
-7.49 |
-18.52 |
3 |
13 |
0 |
160 |
588.562 |
5 |
↓
|
|
|
Analogs
-
4475164
-
-
4499039
-
-
4499043
-
-
4499047
-
-
9207398
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AA1R-2-E |
Adenosine A1 Receptor (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
17 |
0.49 |
Binding ≤ 10μM
|
AA2AR-1-E |
Adenosine A2a Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.51 |
Binding ≤ 10μM
|
AA2BR-1-E |
Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9 |
0.51 |
Binding ≤ 10μM
|
AA3R-2-E |
Adenosine Receptor A3 (cluster #2 Of 6), Eukaryotic |
Eukaryotes |
85 |
0.45 |
Binding ≤ 10μM
|
OXGR1-1-E |
G Protein-coupled Receptor 80 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.47 |
Binding ≤ 10μM
|
AA1R-1-E |
Adenosine A1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.46 |
Functional ≤ 10μM
|
AA2AR-1-E |
Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
394 |
0.41 |
Functional ≤ 10μM
|
AA2BR-1-E |
Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
394 |
0.41 |
Functional ≤ 10μM
|
AA3R-1-E |
Adenosine A3 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
89 |
0.45 |
Functional ≤ 10μM
|
Z100273-1-O |
P3 Purinoceptor (cluster #1 Of 1), Other |
Other |
37 |
0.47 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
40 |
0.47 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
600 |
0.40 |
Functional ≤ 10μM
|
Z50588-3-O |
Canis Familiaris (cluster #3 Of 7), Other |
Other |
150 |
0.43 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
160 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.74 |
-1.18 |
-15.18 |
5 |
10 |
0 |
148 |
308.298 |
3 |
↓
|
|
|
|
|
Analogs
-
3201876
-
-
3201878
-
-
3830179
-
-
3978047
-
-
3978049
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 41 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AA1R-2-E |
Adenosine A1 Receptor (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
5 |
0.61 |
Binding ≤ 10μM
|
AA2AR-1-E |
Adenosine A2a Receptor (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
5 |
0.61 |
Binding ≤ 10μM
|
AA2BR-1-E |
Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.61 |
Binding ≤ 10μM
|
AA3R-2-E |
Adenosine Receptor A3 (cluster #2 Of 6), Eukaryotic |
Eukaryotes |
100 |
0.52 |
Binding ≤ 10μM
|
ADK-1-E |
Adenosine Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8900 |
0.37 |
Binding ≤ 10μM
|
AA1R-1-E |
Adenosine A1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
310 |
0.48 |
Functional ≤ 10μM
|
AA2AR-1-E |
Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
150 |
0.50 |
Functional ≤ 10μM
|
AA3R-1-E |
Adenosine A3 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
290 |
0.48 |
Functional ≤ 10μM
|
ADCY2-1-E |
Adenylate Cyclase Type II (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
150 |
0.50 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
6000 |
0.38 |
Functional ≤ 10μM
|
Z50588-2-O |
Canis Familiaris (cluster #2 Of 7), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
700 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.85 |
-4.39 |
-15.03 |
5 |
9 |
0 |
140 |
267.245 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.31 |
Binding ≤ 10μM |
LT4R2-1-E |
Leukotriene B4 Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
11 |
0.30 |
Binding ≤ 10μM |
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.30 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
74 |
0.27 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
6000 |
0.20 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.90 |
2.39 |
-113.85 |
0 |
7 |
-2 |
115 |
500.547 |
14 |
↓
|
|
|
|
|
|
|
Analogs
-
5820938
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 22 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PE2R1-2-E |
Prostanoid EP1 Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
PE2R2-2-E |
Prostanoid EP2 Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
41 |
0.41 |
Binding ≤ 10μM
|
PE2R3-2-E |
Prostanoid EP3 Receptor (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.46 |
Binding ≤ 10μM
|
PE2R4-2-E |
Prostanoid EP4 Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.48 |
Binding ≤ 10μM
|
PI2R-2-E |
Prostanoid IP Receptor (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
150 |
0.38 |
Binding ≤ 10μM
|
PE2R4-1-E |
Prostanoid EP4 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.47 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
70 |
0.40 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.36 |
7.89 |
-49.67 |
2 |
5 |
-1 |
98 |
353.479 |
13 |
↓
|
Lo
Low (pH 4.5-6)
|
3.36 |
5.91 |
-10.15 |
3 |
5 |
0 |
95 |
354.487 |
13 |
↓
|
|
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 20 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
VDR-1-E |
Vitamin D Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
VDR-1-E |
Vitamin D Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.42 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.38 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
50 |
0.34 |
Functional ≤ 10μM
|
Z80156-5-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #5 Of 12), Other |
Other |
3 |
0.40 |
Functional ≤ 10μM
|
Z80224-2-O |
MCF7 (Breast Carcinoma Cells) (cluster #2 Of 14), Other |
Other |
52 |
0.34 |
Functional ≤ 10μM
|
Z80437-1-O |
RWLeu4 (cluster #1 Of 1), Other |
Other |
6 |
0.38 |
Functional ≤ 10μM |
Z80437-1-O |
RWLeu4 (cluster #1 Of 1), Other |
Other |
6 |
0.38 |
Functional ≤ 10μM |
Z80566-2-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #2 Of 2), Other |
Other |
10 |
0.37 |
Functional ≤ 10μM |
Z80566-2-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #2 Of 2), Other |
Other |
17 |
0.36 |
Functional ≤ 10μM |
Z81117-2-O |
Keratinocytes (Keratinocytes) (cluster #2 Of 2), Other |
Other |
27 |
0.35 |
Functional ≤ 10μM
|
Z81298-1-O |
PE Cell Line (cluster #1 Of 1), Other |
Other |
100 |
0.33 |
Functional ≤ 10μM |
Z81338-2-O |
T-cells (cluster #2 Of 3), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.56 |
6.98 |
-5.55 |
3 |
3 |
0 |
61 |
416.646 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
500 |
0.37 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.42 |
Functional ≤ 10μM
|
Z80055-1-O |
CAKI-1 (Kidney Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.53 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
450 |
0.37 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
82 |
0.41 |
Functional ≤ 10μM
|
Z80117-1-O |
DC3F/AD-II (cluster #1 Of 2), Other |
Other |
110 |
0.41 |
Functional ≤ 10μM
|
Z80125-8-O |
DU-145 (Prostate Carcinoma) (cluster #8 Of 9), Other |
Other |
170 |
0.39 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
99 |
0.41 |
Functional ≤ 10μM |
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
470 |
0.37 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
90 |
0.41 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
960 |
0.35 |
Functional ≤ 10μM
|
Z80244-3-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #3 Of 7), Other |
Other |
270 |
0.38 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
51 |
0.43 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
535 |
0.37 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
48 |
0.43 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
993 |
0.35 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.48 |
Functional ≤ 10μM
|
Z80647-1-O |
833K Cell Line (cluster #1 Of 1), Other |
Other |
328 |
0.38 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4500 |
0.31 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
400 |
0.37 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80776-1-O |
Clone 62 Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80888-1-O |
H2987 Cell Line (cluster #1 Of 1), Other |
Other |
1600 |
0.34 |
Functional ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 4), Other |
Other |
1700 |
0.34 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.47 |
Functional ≤ 10μM
|
Z81020-2-O |
HepG2 (Hepatoblastoma Cells) (cluster #2 Of 8), Other |
Other |
5400 |
0.31 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.36 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
810 |
0.36 |
Functional ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
800 |
0.36 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
70 |
0.42 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
4030 |
0.31 |
ADME/T ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
400 |
0.37 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.23 |
-4.19 |
-10.5 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
Mid
Mid (pH 6-8)
|
-1.23 |
-4.19 |
-11.87 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
|
|
Analogs
-
5430822
-
-
5430826
-
-
6091415
-
-
16941331
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
94 |
0.58 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
10000 |
0.41 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
7500 |
0.42 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
6400 |
0.43 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
9320 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
1010 |
0.49 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
5290 |
0.43 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7400 |
0.42 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
8490 |
0.42 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
5200 |
0.44 |
Functional ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
850 |
0.50 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
2200 |
0.47 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
8200 |
0.42 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
5700 |
0.43 |
Functional ≤ 10μM
|
Z81166-1-O |
LLC Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.48 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
4760 |
0.44 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
1840 |
0.47 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
890 |
0.50 |
ADME/T ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
5290 |
0.43 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6390 |
0.43 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
850 |
0.50 |
ADME/T ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 2), Other |
Other |
510 |
0.52 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
4760 |
0.44 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.52 |
-8.8 |
-12.79 |
5 |
7 |
0 |
126 |
260.271 |
3 |
↓
|
|